Ipca Laboratories will hold a board meeting on November 5, 2026, to consider and approve the standalone and consolidated unaudited financial results for the second quarter and half year ended September 30, 2026, according to a regulatory filing with the BSE Ltd. and National Stock Exchange of India Limited. Trading in the company's securities will be closed for insiders from October 1, 2026, until November 7, 2026, following a prior announcement on September 22, 2026.